RKDA

Insider Trades

Name	Value	Action	Price	Current Price
Kawakami MarkChief Financial Officer $1.7k700 shares BuyFeb 3, 2025 $2.49 --
Schaefer Thomas J.Chief Executive Officer $1.7k700 shares BuyFeb 3, 2025 $2.49 --
Kawakami MarkChief Financial Officer $1.4k700 shares BuyAug 1, 2024 $2.06 --
Schaefer Thomas J.Chief Executive Officer $1.4k700 shares BuyAug 1, 2024 $2.06 --

News

globenewswire.comArcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rulesglobenewswire.comJun 12

globenewswire.comArcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rulesglobenewswire.comJun 11

globenewswire.comArcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlightsglobenewswire.comMay 14

Trade RKDA

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.

CEO: Thomas J. Schaefer
IPO Date: May 15, 2015

Market Data

Open: $0.82
High: $0.82
Low: $0.7774
Volume: 71.2K
Avg Volume: 3M
52W High: $6.71
52W Low: $0.765

Valuation

Market Cap: $1.2M
Enterprise Value: $249k
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-4.7M
Revenue: $4.9M
Net Income: $-2.3M
Cash: $259k
Debt: $0

Events

EarningsAug 19

EPS est. -0.56